Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:M* Explains Analyst Ratings Not Rated 0.0 Email Routing List Email & Route  Print Print
Monday, April 1, 2013

M* Explains Analyst Ratings

News summary by MFWire's editors

Just what goes into the Morningstar analyst rating of a fund?

The research firm gives some insights into this process in an article dubbed Our Mostly Patient Approach to Analyst Ratings.

In the article, director of mutual fund research Russel Kinnel drills down on the firm's thinking in relation to six fund ratings.

The fund ratings in question include:
1. The Neutral rating of the  T. Rowe Price Health Sciences fund
2. The Gold rating of the Harbor Bond fund
3. The Negative rating of the Templeton Developing Markets fund
4. The Silver rating of the FPA Capital fund
5. The Gold rating of the  Primecap Odyssey Aggressive Growth
6.The Bronze rating of theCalamos Convertible fund

The "patient" part of the Morningstar ratings for most of these funds involves the ups and downs many of the ratings took due to various changes that led to downgrades, upgrades and sometimes downgrades followed by upgrades. For some, it was a matter of Morningstar stick to its guns.

For more on the twists and turns of these ratings, go to the Morningstar article

Edited by: Tommy Fernandez


Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use